News

listing-news

Latest News

No Results Found

Try adjusting your search to find what you’re looking for.

10/26/2023

Cancer Screening and the Path Forward

A recent meta-analysis published in JAMA Internal Medicine (August 2023) found no evidence that the most common types of cancer screening are providing statistically significant benefits in overall survival, with the exception of colorectal cancer screening with sigmoidoscopy. How can this be?

Read More
10/18/2023

Actym Closes $59.5 Million Series A with New $25.5 Million Extension

Actym Therapeutics, pioneering a new drug modality to treat solid tumors, announced today it has extended its Series A financing round with an additional close of $25.5 million, bringing the total Series A amount raised to $59.5 million.

Read More
10/05/2023

Precede Biosciences Emerges from Stealth to Dramatically Impact Precision Medicine with a First-In-Class Liquid Biopsy Platform

Precede Biosciences emerges from stealth today with a breakthrough, comprehensive, blood-based approach to revealing disease-defining transcriptional biology – a first for the diagnostic field.

Read More
10/03/2023

Iambic Therapeutics Announces Close of Oversubscribed $100 Million Series B Financing to Advance AI-Discovered Therapeutics into Clinical Development and Enters Collaboration with NVIDIA

Iambic’s unique AI-Driven drug-discovery platform identifies potential first-in-class and best-in-class development candidates years faster than industry norms. Funding will support continued AI platform innovations and advancement of multiple candidates into clinical development, Including IAM-H1, a selective brain-penetrant HER2 Inhibitor, and IAM-C1, a selective dual CDK2/4 inhibitor.

Read More